switching from compounded semaglutide to zepbound a GLP-1: A Step-by-Step Guide Zepbound (tirzepatide) superior to Wegovy

Ensure your refrigerator is set to the correct temperature and that the vial is not placed near the freezer compartment or ice-making section

In Phase 2 research reported in The New England Journal of Medicine , participants began treatment with a low introductory dose, typically between 2 and 4 mg per week, and gradually increased to target doses ranging from 8 to 12 mg over several weeks

A large study that compared tirzepatide to semaglutide showed that in non-diabetic, overweight adults, the risk of gastroparesis was much higher in semaglutide recipients compared to tirzepatide

The Bottom Line The most accurate GLP-1 side effects timeline is not a straight line from "sick in week 1" to "fully adjusted by month 3." Digestive symptoms are common early and during dose escalation